Evidence map›Paper›PMID 31084291›Full record

Trial reportPsychiatric services (Washington, D.C.)2019

Predictors of Hospitalization of Individuals With First-Episode Psychosis: Data From a 2-Year Follow-Up of the RAISE-ETP.

Delbert G Robinson, Nina R Schooler, Robert A Rosenheck, Haiqun Lin, Kyaw J Sint, Patricia Marcy, John M Kane

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychiatric services (Washington, D.C.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Specialised early intervention teams for recent-onset psychosis.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology.International journal of molecular sciences · 2020
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Delbert G RobinsonDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Feinstein Institute for Medical Research, Manhasset, New York (Robinson, Kane); Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, New York (Schooler); Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut (Rosenheck); Yale School of Public Health, New Haven (Lin, Sint); Vanguard Research Group, Glen Oaks, New York (Marcy).
Nina R SchoolerDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Feinstein Institute for Medical Research, Manhasset, New York (Robinson, Kane); Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, New York (Schooler); Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut (Rosenheck); Yale School of Public Health, New Haven (Lin, Sint); Vanguard Research Group, Glen Oaks, New York (Marcy).
Robert A RosenheckDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Feinstein Institute for Medical Research, Manhasset, New York (Robinson, Kane); Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, New York (Schooler); Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut (Rosenheck); Yale School of Public Health, New Haven (Lin, Sint); Vanguard Research Group, Glen Oaks, New York (Marcy).
Haiqun LinDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Feinstein Institute for Medical Research, Manhasset, New York (Robinson, Kane); Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, New York (Schooler); Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut (Rosenheck); Yale School of Public Health, New Haven (Lin, Sint); Vanguard Research Group, Glen Oaks, New York (Marcy).
Kyaw J SintDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Feinstein Institute for Medical Research, Manhasset, New York (Robinson, Kane); Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, New York (Schooler); Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut (Rosenheck); Yale School of Public Health, New Haven (Lin, Sint); Vanguard Research Group, Glen Oaks, New York (Marcy).
Patricia MarcyDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Feinstein Institute for Medical Research, Manhasset, New York (Robinson, Kane); Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, New York (Schooler); Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut (Rosenheck); Yale School of Public Health, New Haven (Lin, Sint); Vanguard Research Group, Glen Oaks, New York (Marcy).
John M KaneDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Feinstein Institute for Medical Research, Manhasset, New York (Robinson, Kane); Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, New York (Schooler); Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut (Rosenheck); Yale School of Public Health, New Haven (Lin, Sint); Vanguard Research Group, Glen Oaks, New York (Marcy).
Feinstein Institute for Medical Research · US

Funding

Trials Operation Unit (OPERATIONS CORE)P30MH090590 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORRELL, CHRISTOPH U · 2010 to 2014
$7.9M
Longitudinal Mediation Analysis to Identify Effective Intervention Components in Clustered Trial of RAISE-ETP (Recovery after an Initial Schizophrenia Episode-Early Treatment Program)R03MH112053 · NIMH · YALE UNIVERSITY · PI LIN, HAIQUN · 2017 to 2018
$168k
NIMH NIH HHS HHSN271200900019CNIMH NIH HHS P30 MH090590NIMH NIH HHS R03 MH112053
6 · The paper itself

Abstract

objectiveDespite treatment advances in other domains, inpatient psychiatric hospitalization rates for individuals with first-episode psychosis remain high. Even with early intervention services, a third or more of individuals are hospitalized over the first 2 years of treatment. Reducing hospitalization is desirable from the individual's perspective and for public health reasons because hospitalization costs are a major component of treatment costs.

methodsUnivariate and multivariate baseline and time-varying covariate analyses were conducted to identify predictors of hospitalization in the Recovery After an Initial Schizophrenia Episode-Early Treatment Program (RAISE-ETP) study, a 2-year cluster randomized trial for participants experiencing a first episode of psychosis who were outpatients at study entry. The trial compared an early intervention treatment model (NAVIGATE) with usual community care at 34 clinics across the United States.

resultsRAISE-ETP enrolled 404 participants of whom 382 had one or more postbaseline assessments that included hospitalization data. Thirty-four percent of NAVIGATE and 37% of usual-care participants were hospitalized during the trial. Risk analyses revealed significant predictors of hospitalization to be the number of hospitalizations before study entry; duration of untreated psychosis; and time-varying days of substance misuse, presence of positive symptoms, and beliefs about the value of medication.

conclusionsThese results indicate that hospital use may be decreased by reducing the duration of untreated psychosis and prior hospitalizations, minimizing residual symptoms, preventing substance misuse, and facilitating adherence to medication taking. Addressing these factors could enhance the impact of first-episode early intervention treatment models and also enhance outcomes of people with first-episode psychosis treated using other models.

Indexed as

Early Medical InterventionHealth Knowledge, Attitudes, PracticeHospitalizationOutcome and Process Assessment, Health CareAdolescentAdultFemaleFollow-Up StudiesHumansPsychotic DisordersRiskSchizophreniaSubstance-Related DisordersTime FactorsYoung Adultadherenceduration of untreated psychosisfirst-episode psychosishospitalizationpositive symptomssubstance misuse

Identifiers

PMID31084291
PMCPMC6602852
OpenAlexW2946467974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.